
Among patients with severe community-acquired pneumonia and high initial inflammatory response, the use of the corticosteroid methylprednisolone decreased treatment failure, compared with placebo, according to a new study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/LqSDtx5HyhQ/150217114001.htm